Close Menu

More articles about Sample Prep

The companies will comarket Thermo Fisher's NGS library preparation kits with SPT Labtech's Mosquito HV Genomics and Dragonfly Discovery automation systems.

The Seattle-based University of Washington spinout is planning to scale up the commercial roll-out of its single-cell, whole-transcriptome assay kit.

The company plans to use to the funds to accelerate the commercialization of its CRISPRclean technology and expand into additional markets.

The two devices can be used to collect saliva specimens for over-the-counter in-home testing kits and prescription-only in vitro diagnostics, respectively.

The joint venture will further develop, manufacture, and distribute LevitasBio's magnetic levitation-based cell separation and purification platform in China. 

New cellular and molecular spatial biology methods, companies, and product offerings have made this area one of the hottest in the life science market.

Boston-based NanoView aims to use its ExoView platform to understand the biological role of extracellular vesicles and their use as disease biomarkers.

The agreement will allow life science researchers in Switzerland better access to the image-based CellRaft AIR system's instrument, consumables, and support.

The firm is planning to use its platform to offer a spatial gene expression analysis service early next year, with other analytes to follow.

Canadian Life Science distributes a range of consumables for chromatography including liquid and gas chromatography columns as well as sample prep products.

Ceres plans to develop its Nanotrap technology to isolate undetectable levels of circulating tumor DNA in blood samples from non-small cell lung cancer patients.

During its Nanopore Community Meeting, held online this year, the firm announced several product releases, technology improvements, and development projects.

The collaboration is part of a public health surveillance initiative with the US Department of Health and Human Services and eTrueNorth.

The kit is designed for use with samples stored in the company's CE-marked DNA/RNA Shield sample collection and preservation devices.

The firm also discussed recent studies comparing its UltraSeek lung cancer assay with more established liquid biopsy tests to detect drug-resistant mutations.

In a study involving 1,300 blood samples from pregnant women, Myriad researchers demonstrated that their method could increase the fetal fraction for almost all.

In their first conference call with investors, PacBio's new CEO and CFO laid out a strategic plan for the company as it weathers the COVID-19 pandemic.

At the ASHG 2020 virtual meeting, researchers presented data showing they could use the method to enrich for placental DNA in maternal plasma samples.

The saliva collection devices are designed for use with third-party SARS-CoV-2 tests or home/self-collection kits and are not intended for sale to patients.

The firms will market Roche's Kapa HyperExome whole-exome sequencing probes alongside Fabric's Enterprise bioinformatics and analysis platform.


The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.